type here...

CATEGORIES

Mental Health

LATEST

1...192021...52Page 20 of 52

TRENDING

EDITORS CHOICE

The Amazon and One Medical Combo May Not Disrupt the Health System Now – They Will Champion its Transformation

Gil Bashe, Medika Life Editor -
The Company’s Four Chief Medical Officers Steering Team Share a Vision for Patient Care

Before Looking at the Results of the Paper on MDMA to Treat PTSD…

James Coyne -
So what really is the truth about MDMA and PTSD. Does this research published in Science hold up to scrutiny is is there a problem. Watch this space

What Can You Do To Prevent Developing a Chronic Disease?

Stephen Schimpff, MD MACP -
Healthy lifestyles mean more years of healthy life. And remember, it was not just more years of life but fewer chronic illnesses for a longer “health span.”

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

Medika Life -
SPRAVATO® (esketamine) CIII nasal spray, taken with an oral antidepressant, to treat depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories